Although it is widely recognized that a product will be more successful in the long-run if those in clinical development work hand-in-hand with marketing and commercialization teams, it is not widely practiced. The product development cycle for new products continues to be extremely costly and lengthy. Identifying which products have the highest market potential allows companies to prioritize their resources to make earlier Go/No Go decisions. Working together on clinical trial development will also allow them to plan toward outcomes that will help create evidence to back up value claims when looking for reimbursement. This annual conference provides strategies for balancing clinical and commercial needs and priorities early in the development cycle to maximize products’ potentials.

Contact: Daniel Dunn - Program Manager - (339) 298-2104 or Daniel.dunn@cbinet.com

Since the inaugural program in November of 2007, CBI has emerged as the leading provider of critical information on the use of Patient Reported Outcomes.

Historically focused on operationalizing the February 2006 FDA Draft Guidance, CBI’s 4th Patient Reported Outcomes is designed to generate high-level discussion on a myriad of PRO topics designed to maximize the value of your data.

Top Reasons to Attend Include:

• An in-conference workshop on interpreting change and responder analysis for PROs
• FDA inspired guidance on building a structure for PRO submissions
• Strategies for creating product differentiation and gaining a competitive advantage by promoting PRO data
• An in-depth discussion on integrating ePRO with EDC

Contact: Kevin Palmaccio - Program Manager - (339) 298-2101 or Kevin.palmaccio@cbinet.com

The Pharma CI Conference & Exhibition is the largest and best gathering of senior level pharma, biotech, medical device, and diagnostic executives in competitive intelligence. We are featuring an unprecedented 70+ expert speakers in 50+ sessions this year that spans all the most critical topics of today and includes all the leaders of this industry.

Building on the momentum of last year's historic, sold out event, the 2009 Pharma CI Conference is on track for even more success. This event is known for impactful networking for everyone who attends because we truly bring together all the intelligence industry's heavy hitters under one roof. The "who's who" will all be there.

To register or for more information, please call 1.212.228.7974 or visit http://www.pharmaciconference.com/